Treatment of Allergic Rhinitis With Desloratadine: Results of a Multinational Observational Study in the Middle East Gulf Region

BACKGROUND: Allergic rhinitis (AR) affects up to 36% of the population in the Middle East Gulf States. The second-generation nonsedating antihistamine desloratadine has demonstrated safety and efficacy in the treatment of AR; however, few studies have evaluated this agent in Arab and Asian populatio...

Descripción completa

Detalles Bibliográficos
Autor principal: Adham, Tamer MH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651107/
https://www.ncbi.nlm.nih.gov/pubmed/23282541
http://dx.doi.org/10.1097/WOX.0b013e31822a6e9a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651107/
https://www.ncbi.nlm.nih.gov/pubmed/23282541
http://dx.doi.org/10.1097/WOX.0b013e31822a6e9a

Ejemplares similares